James Wilson Offers Legal Assistance to Rite Aid Shareholders Who Lost More Than $100,000
April 7, 2023
Trending News 🌧️
James Wilson, Partner at Securities Litigation, is offering legal assistance to those who invested in Rite Aid ($NYSE:RAD) and suffered losses of more than $100,000. Investors are encouraged to reach out to James directly to discuss their particular situation. The company offers a variety of products, including prescription medications, health and beauty products, general merchandise, and food and beverages.
In addition, Rite Aid also provides digital and online services, such as online ordering and delivery services. Over the years, the company has seen its stock prices rise and fall, bringing opportunities for investors to gain or lose money. Unfortunately, many investors lost significant sums due to the volatility of the stock, and James Wilson is offering them a chance to gain back some of their losses.
Stock Price
The stock opened at $2.3 and closed at $2.2, representing a 3.6% decrease from its last closing price of 2.2. The steep drop in the value of shares has caused major financial losses for many shareholders and has prompted legal action. James Wilson is now offering his services to provide legal counseling, advice and representation to aggrieved investors. He is committed to helping shareholders recoup their losses and obtain justice for their financial hardship. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Rite Aid. More…
| Total Revenues | Net Income | Net Margin |
| 24.06k | -897.69 | -2.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Rite Aid. More…
| Operations | Investing | Financing |
| 23.86 | -113.41 | 37.31 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Rite Aid. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 8.21k | 8.61k | -7.14 |
Key Ratios Snapshot
Some of the financial key ratios for Rite Aid are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 3.7% | -4.7% | -2.8% |
| FCF Margin | ROE | ROA |
| -0.9% | 115.7% | -5.2% |
Analysis
GoodWhale recently conducted an analysis of RITE AID‘s wellbeing and the results are in. We have determined that RITE AID is a medium risk investment in terms of its financial and business aspects. In our analysis, we uncovered two risk warnings in the income sheet and balance sheet. To take a closer look at these risk warnings and discover more insights into RITE AID’s wellbeing, register with us. With GoodWhale, you can easily access the most up-to-date information on the company to make the best investment decisions. We want to provide you with all the tools you need to make informed decisions about investments. That’s why we are continually updating our analysis of RITE AID and other companies. Take advantage of our insights today by registering with us. More…
Peers
The company operates through a network of approximately 4,600 stores in 31 states. Rite Aid Corp is the third largest pharmacy chain in the US. The company’s main competitors are COSMOS Pharmaceutical Corp, Clicks Group Ltd, Yifeng Pharmacy Chain Co Ltd.
– COSMOS Pharmaceutical Corp ($TSE:3349)
COSMOS Pharmaceutical Corp is a Japanese pharmaceutical company with a market cap of 575.37B as of 2022. The company’s return on equity is 10.84%. The company develops and manufactures prescription drugs, over-the-counter drugs, and medical devices. The company’s products include treatments for cancer, diabetes, and infectious diseases.
– Clicks Group Ltd ($OTCPK:CLCGY)
Clicks Group Ltd is a South African company that operates in the healthcare and beauty retail sector. The company operates through two segments: Retail and Supplies. The Retail segment comprises of Clicks, GNC, The Body Shop, and Musica. The Supplies segment includes UPD, the leading pharmaceutical and medical wholesaler in Southern Africa. Clicks Group Ltd has a market cap of 4.32B as of 2022. The company has a Return on Equity of 46.27%.
– Yifeng Pharmacy Chain Co Ltd ($SHSE:603939)
Yifeng Pharmacy Chain Co Ltd has a market cap of 41.14B as of 2022, a Return on Equity of 12.88%. Yifeng is a pharmacy chain in China with over 1,000 stores. The company offers prescription and over-the-counter drugs, as well as health and beauty products.
Summary
Rite Aid is a publicly traded company on the New York Stock Exchange, and investors may have suffered significant losses due to the company’s stock price decline. A partner in securities litigation, James Wilson, is encouraging investors who have lost more than $100,000 in Rite Aid to contact him directly for a discussion about their losses. Investment analysis of Rite Aid is complex and should include evaluating the company’s financial health, potential liquidity issues, potential governance issues, and debt concerns.
Additionally, investors should be aware of the company’s strategic direction, competitive landscape, and risk factors. Analyzing Rite Aid’s past performance and recent news should also be taken into consideration when making an investment decision.
Related Posts
Recent Posts
